Choksi Laboratories informed about an inspection by the US Food & Drug Administration at its central laboratory in Indore.

Following the inspection, the company received 4 observations.

Choksi Laboratories stated it is comprehensively addressing these observations and will respond to the USFDA within the required timeframe.

The company reaffirmed its commitment to maintaining the highest quality and regulatory compliance standards, which is crucial for its operations and market access.